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Abstract
The effects of increased intra-abdominal pressure (IAP) on cardiovascular function are well recognized and include 
a combined negative effect on preload, afterload and contractility. The aim of this review is to summarize the cur-
rent knowledge on this topic. The presence of intra-abdominal hypertension (IAH) erroneously increases barometric 
filling pressures like central venous (CVP) and pulmonary artery occlusion pressure (PAOP) (since these are zeroed 
against atmospheric pressure). Transmural filling pressures (calculated by subtracting the pleural pressure from the 
end-expiratory CVP value) may better reflect the true preload status but are difficult to obtain at the bedside. Alterna-
tively, since pleural pressures are seldom measured, transmural CVP can also be estimated by subtracting half of the 
IAP from the end-expiratory CVP value, since abdominothoracic transmission is on average 50%. Volumetric preload 
indicators, such as global and right ventricular end-diastolic volumes or the left ventricular end-diastolic area, also 
correlate better with true preload. When using functional hemodynamic monitoring parameters like stroke volume 
variation (SVV) or pulse pressure variation (PPV) one must bear in mind that increased IAP will increase these values 
(via a concomitant increase in intrathoracic pressure). The passive leg raising test may be a false negative in IAH. 
Calculation of the abdominal perfusion pressure (as mean arterial pressure minus IAP) has been shown to be a better 
resuscitation endpoint than IAP alone. Finally, it is re-assuring that transpulmonary thermodilution techniques have 
been validated in the setting of IAH and abdominal compartment syndrome. In conclusion, the clinician must be 
aware of the different effects of IAH on cardiovascular function in order to assess the volume status accurately and 
to optimize hemodynamic performance. 
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fluid responsiveness, passive leg raising
Obviously, any mechanically ventilated patient that is 
at risk of developing intra-abdominal hypertension (IAH) or 
abdominal compartment syndrome (ACS) with shock should 
be hemodynamically monitored [1]. Conversely, since IAH has 
an impact on every organ within and outside the abdomen 
any patient that develops one or more organ failure should be 
screened for increased intra-abdominal pressure (IAP) [2−4]. 
IAH affects multiple organ systems in a graded fashion and 
in order to better understand the clinical presentation and 
management of IAH, one must understand the physiologic 
derangements within each organ system separately [5]. It is 
beyond the scope of this review to give a complete overview 
of the pathophysiologic implications of raised IAP. We will 
only discuss some key messages related to cardiovascular 
function that will affect the daily clinical practice of the ICU 
physician and we will provide the reader with some practical 
hints and tips for patient management decisions. Cardiovas-
cular dysfunction and failure and hemodynamic instability 
are commonly encountered in patients with IAH or ACS and 
the different effects are listed in Table 1 [6]. As such, accurate 
assessment and optimization of preload, contractility, and 
afterload, together with appropriate goal-directed resus-
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citation are essential in restoring end-organ perfusion [7]. 
A Medline and Pubmed literature search was performed in 
order to find an answer to the question “What is the impact of 
increased IAP on cardiovascular function?”, using the search 
terms “abdominal compartment syndrome” or “abdominal 
hypertension” or “abdominal pressure” and “cardiac output” 
or “preload” or “afterload” or “contractility” or “cardiovascular” 
or “hemodynamic”. This search yielded many references, most 
of which were not relevant to the subject of this paper. The 
selected abstracts were screened and selected on the basis 
of relevance, methodology, and scientific merit. Full text ar-
ticles of the selected abstracts were used to supplement the 
authors’ expert opinion and experience. The references of the 
selected papers were also checked for other relevant material. 
The resulting references were included in the current review 
on the basis of relevance and scientific merit.
CARDIOVASCULAR EFFECTS ASSOCIATED WITH 
INTRA-ABDOMINAL HYPERTENSION
IAH is associated with a number of effects on the cardio-
vascular system that are caused by multiple factors [1, 8]. 
First of all, due to the upward movement of the diaphragm 
during IAH, the intrathoracic pressure (ITP) and hence also 
pleural pressure will rise. Animal and human experiments 
have shown that between 20% and 80% or thus on average 
50% of the IAP is transmitted to the thorax [9, 10]. Cephalad 
movement of the diaphragm leads to direct compression 
on the heart with reduction of the right and left ventricle 
end-diastolic volumes. Secondly, the cardiac preload de-
creases due to decreased venous return from the abdomen 
and the systemic afterload is increased due to direct compres-
sion of vascular beds and activation of the renin-angioten-
sin-aldosteron pathway [11]. This leads to decreased cardiac 
output (CO). Although mean arterial blood pressure (MAP) 
may rise initially due to the shunting of blood away from the 
abdominal cavity (a sort of autotransfusion effect), it usually 
normalizes, or even decreases thereafter. The different ef-
fects on preload, afterload and contractility are summarized 
in Figure 1. The cardiovascular effects can be aggravated in 
hypovolemic patients and with the application of high levels 
of positive end-expiratory pressure (PEEP) [12, 13], whereas 
hypervolemia usually has a temporary protective effect [14]. 
Cardiac function may be distilled into three essential compo-
nents: preload, contractility, and afterload. Moreover, elevated 
IAP has negative effects on all three of these interrelated 
components as will be explained below [15]. 
EFFECT OF INTRA-ABDOMINAL HYPERTENSION ON 
PRELOAD
PATHOPHYSIOLOGY
Increased IAP results in direct vascular compression and 
diaphragm elevation. Vascular compression on the inferior 
vena cava (IVC) reduces the flow, while diaphragm elevation 
increases ITP and causes cardiac compression (Fig. 1). Since 
barometric filling pressures are zeroed against atmospheric 
pressure, preload assessment becomes difficult in patients 
with IAH/ACS [1]. First, as originally described by Coombs, 
intrathoracic pressure (ITP) is increased as a result of a ceph-
alad movement of the diaphragm due to increased IAP [16]. 
The elevated ITP is directly transmitted to the intravascular 
pressures, such as the central venous (CVP) and pulmonary 
Table 1. Cardiovascular effects related to increased IAP*
Diaphragm elevation and cardiac compression á
Pleural and intrathoracic pressure (ITP) á
Difficult preload assessment
Pulmonary artery occlusion pressure (PAOP) á
Central venous pressure (CVP) á
Mean systemic filling pressure á
Transmural filling pressure =æ
Intra thoracic blood volume (ITBV) =æ
Global end-diastolic volume (GEDV) =æ
Right ventricular end-diastolic volume (RVEDV) =æ
Right, global and left ventricular ejection fraction =æ
Extra vascular lung water (EVLW) =ä
Stroke volume variation (SVV) ä
Pulse pressure variation (PPV) ä
Systolic pressure variation (SPV) ä (Δdown =, Δup á)
Inferior vena caval flow â
Venous return â
Left ventricular compliance and contractility â
Downward and rightward shift of Frank- Starling curve
Cardiac output â
Systemic vascular resistance (SVR) á
Mean arterial pressure (MAP) ä =æ
Pulmonary artery pressure (PAP) á
Pulmonary vascular resistance (PVR) á
Heart rate ä =
Lower extremity hydrostatic venous pressure á
Venous stasis, edema, ulcers á
Venous thrombosis á
Pulmonary embolism# á
Mixed venous oxygen saturation â
Central venous oxygen saturation â
False negative passive leg raising test á
Functional hemodynamic thresholds for fluid responsiveness á
*cardiovascular effects are exacerbated in case of hypovolemia, 
haemorrhage, ischemia, auto-PEEP or high PEEP ventilation
#risk of pulmonary embolism upon decompression
á — increase; áá — huge increase; ä — small increase; æ — small decrease;  
â — decrease; ââ — huge decrease
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artery occlusion pressure (PAOP). As suggested, the elevated 
ITP also decreases blood flow through the IVC and limits 
blood return from below the diaphragm in a pressure-de-
pendent manner [9, 17]. Together with increased IVC and 
femoral vein pressures, parallel changes in IAP can be ob-
served. Some have even suggested that IVC pressure could 
be used as a surrogate for IAP [18]. Secondly, when IAP rises, 
the cranial deviation of the diaphragm compresses and 
narrows the IVC as it passes through the diaphragm, further 
reducing venous return, and this may occur at an IAP as 
low as 10 mm Hg [19]. The resulting reduced venous return 
has an immediate effect on CO through decreased stroke 
volume (SV). As a result, mixed venous and central venous 
oxygen saturation may fall. Similar effects are encountered 
during laparoscopic surgery and these changes place the 
patient with IAH at risk of deep venous thrombosis and 
pulmonary embolism at the time of abdominal decompres-
sion [20, 21]. Lower extremity hydrostatic venous pressure 
increases and clinical examination may show venous stasis, 
edema and leg ulcers in cases of chronic IAH, as seen with 
obesity.
INTRACARDIAC FILLING PRESSURES ARE INACCURATE 
DURING IAH
According to the Frank-Starling principle, ventricular 
preload is defined as myocardial muscle fiber length at 
end-diastole (Fig. 2). Ideally, the appropriate clinical corre-
late would be left ventricular end-diastolic volume (LVEDV), 
but this physiologic parameter is not easily measured on 
a serial basis [1, 8]. If we assume that a patient’s ventricular 
compliance remains constant, changes in ventricular vol-
ume should be reflected by changes in ventricular pressure 
through the following relationships:
Compliance = D Volume / D Pressure
and
D Volume  D Pressure
Based upon the assumption of stable ventricular com-
pliance, pressure-based parameters such as left ventricular 
end-diastolic pressure (LVEDP), left atrial pressure (LAP), 
and PAOP, have long been utilized clinically as surrogate 
estimates of intravascular volume. Although likely to be valid 
in normal healthy individuals, the multiple assumptions 
necessary to utilize PAOP and CVP as estimates of left and 
right ventricular preload status respectively, are not neces-
sarily true in the critically ill patient with IAH or ACS (Fig. 2). 
Hemodynamic monitoring can only improve patient 
care and outcomes when clinicians thoroughly understand 
both the appropriate utilization, as well as the potential 
measurement errors associated with the use of parameters 
such as PAOP and CVP. Due to the physiologic complex-
ity of patients with IAH or ACS, resuscitation to arbitrary, 
absolute PAOP or CVP values should be avoided as such 
a practice can lead to inappropriate therapeutic decisions, 
under-resuscitation, and organ failure. 
Figure 1. Cardiovascular effects (on preload, afterload and contractility) related to increased intra-abdominal pressure
4Anaesthesiol Intensive Ther [ahead of print]
IMPROVEMENT OF BAROMETRIC PRELOAD INDICES 
(TRANSMURAL CARDIAC FILLING PRESSURES)
Recognizing the impact of elevated IAP and ITP on the 
validity of intracardiac filling pressure measurements, some 
authors have suggested calculating the transmural PAOP 
(PAOPtm) or CVP (CVPtm) in an attempt to improve the ac-
curacy of PAOP and CVP as resuscitation endpoints in animal 
studies with IAH [9, 10, 22]. Assuming the proper placement 
of a PAC and the absence of other confounding factors, 
PAOPtm may be calculated as end-expiratory PAOP (PAOPee) 
minus ITP with CVPtm calculated as CVPee-ITP. 
•	 Theoretical transmural (tm) filling pressures, calculated 
as the endexpiration value (ee) minus the ITP may better 
reflect true preload. 
•	 CVPtm = CVPee – ITP
•	 PAOPtm = PAOPee – ITP
The ITP is usually estimated by pleural pressure (Ppl) 
which in turn is typically determined by measuring lower es-
ophageal pressure using a balloon catheter. Studies showed 
that there is a good correlation between Ppl and IAP [9, 23, 
24]. Different studies found that around 20−80% (or on 
average 50%) of IAP is transmitted to the thorax, a feature 
which is termed the abdomino-thoracic index of transmis-
sion [10]. As a rule of thumb, a quick estimate of transmural 
filling pressures can be obtained by subtracting half of the 
IAP from the measured filling pressure [25]. 
•	 A quick estimate of transmural filling pressures can also 
be obtained by subtracting half of the IAP from the 
end-expiratory filling pressure 
•	 CVPtm = CVPee – IAP/2
•	 PAOPtm = PAOPee – IAP/2
Alternatively, one can calculate the index of transmis-
sion, which can easily be calculated at the bedside (Fig. 3). 
This can be done by looking at changes in IAP (ΔIAP, e.g. by 
means of a Velcro belt or abdominal compression) versus 
changes in CVP (ΔCVP). The abdomino-thoracic index of 
transmission (ATI) can thus be calculated as ΔCVP divided 
by ΔIAP. 
•	 The real transmural filling pressures can be calculated 
as follows:
•	 CVPtm = CVPee – (ATI x IAP)
•	 With ATI = ΔCVP/ ΔIAP 
•	 PAOPtm = PAOPee – (ATI x IAP)
It has not been shown that real measurement of pleural 
pressure by an esophageal catheter improves the ability of 
PAOP alone to predict volume recruitable increases in CO [1, 
25]. Although physiologically sound, the use of transmural 
filling pressures cannot be recommended in clinical practice 
as no studies have investigated this.
Figure 2. “The PAOP Assumption”: why intracardiac filling pressures like pulmonary artery occlusion pressure do not accurately estimate preload 
status. First, ventricular compliance is constantly changing in the critically ill, resulting in a variable relationship between pressure and volume.  
As a result, changes in intracardiac pressure no longer directly reflect changes in intravascular volume. The presence of IAH will decrease LV 
compliance by rightward shift and flattening of the Frank-Starling curve. Second, the elevated ITP associated with IAH has been demonstrated to 
increase PAOP and CVP measurements by an amount that is difficult to predict, further confounding their validity.  This apparent deviation from 
Starling’s Law of the Heart is due to the fact that both PAOP and CVP are measured relative to atmospheric pressure but are actually the sum of 
both intravascular pressure and intrapleural pressure. Third, mitral valve disease can confound the use of PAOP as an estimate of intravascular 
volume status. Patients with IAH-induced pulmonary hypertension or acute lung injury demonstrate increased PVR and are at significant risk 
for mitral valve regurgitation. Fourth, accurate PAOP measurements are dependent upon proper placement of the PAC.  Compression of the 
pulmonary parenchyma as a result of elevated IAP can markedly alter the normal progression of alveolar distention and pulmonary capillary 
pressures defined in West’s lung zones 1, 2 and 3.  IAH-induced cardiac and pulmonary dysfunction can further alter the normal pulmonary artery 
waveforms making proper placement of the PAC tip in West’s lung zone 2 difficult.  Inadvertent placement of the tip in apical zone 1 commonly 
results in PAOP measurements that more appropriately reflect alveolar pressure. Adapted from Cheatham et al [1] “The PAOP Assumption”: why 
intracardiac filling pressures like pulmonary artery occlusion pressure do not accurately estimate preload status. Caption: LVEDV — left ventricular 
end-diastolic volume; LVEDP — left ventricular end-diastolic pressure; LAP — left atrial pressure; PAOP — pulmonary artery occlusion pressure.
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The calculation of transmural pressures may be better to 
estimate preload in patients with IAH or ACS for a number of 
reasons.  This is because both PAOP and CVP are measured 
relative to atmospheric pressure and are actually the sum 
of intravascular pressure and ITP. Furthermore, ventricular 
compliance is dynamically changing from beat-to-beat in 
the critically ill, resulting in a variable relationship between 
pressure and volume [26]. As a result, changes in intravas-
cular pressure no longer reflect changes in intravascular 
volume, further reducing the accuracy of intracardiac filling 
pressures such as PAOP and CVP as estimates of preload 
status.
THE ROLE OF VOLUMETRIC PRELOAD  
MONITORING IN IAH 
Volumetric preload monitoring can be done with either 
the continuous right ventricular end-diastolic volume index 
(RVEDVI) obtained with the PAC (transcardiac thermodilu-
tion) or via the intermittent global end-diastolic volume 
index (GEDVI) obtained with either the PiCCO (Pulsion 
Medical Systems, Munich, Germany) or EV1000 (Edwards 
Lifesciences, Irvine, CA, USA) system (transpulmonary 
thermodilution, TPTD). To calculate the RVEDVI, the right 
ventricular ejection fraction (RVEF) reflecting the patient’s 
right ventricular contractility and afterload, is utilized using 
the following equation (where SVI = stroke volume index):
RVEDVI = SVI / RVEF
Independent of the effects of changing ventricular com-
pliance and increased ITP or IAP, RVEDVI has been shown 
in multiple studies to be an accurate indicator of preload 
recruitable increases in CO in a variety of patient popula-
tions [27, 28]. With concerns over the safety and efficacy of 
the PAC in the management of the critically ill, several less 
invasive hemodynamic monitoring technologies have been 
proposed [29, 30]. The PiCCO system is less invasive and 
combines two techniques namely, intermittent TPTD (as 
calibration) and an estimation of SV based upon analysis 
of a patient’s arterial pressure waveform or contour. This 
technique, known as arterial pulse contour analysis, has 
been proposed as a less invasive alternative [31]. Due to 
the unique mechanical characteristics of each patient’s arte-
rial tree, initial calibration of the monitoring system using 
the TPTD technique and the Stewart Hamilton equation 
is needed and this greatly improves accuracy compared 
to uncalibrated continuous pulse contour CO techniques 
like Lidco rapid or Vigileo, as has been recently shown [32]. 
Assessment of the mean transit time (MTT) and 
downslope time (DST) during the TPTD, allows the calcula-
tion of other derived parameters: global ejection fraction 
(GEF), an estimate of ventricular contractility, and several 
intravascular volume measurements including GEDV and 
extravascular lung water (EVLW), as surrogate predictors 
of cardiac preload and capillary leak. 
GEF = (4 × SVI)/GEDVI 
VOLUMETRIC PRELOAD INDICES BETTER REFLECT  
THE TRUE PRELOAD STATUS IN IAH 
The value of RVEDVI over traditional intracardiac filling 
pressures is especially notable in patients with elevated ITP 
or IAP where PAOP and CVP are at greatest risk for providing 
erroneous information regarding preload status. Elevated 
ITP and IAP result in significant decreases in GEDVI despite 
paradoxical increases in measured PAOP and CVP [13, 33]. 
Based upon these studies and others, although it is clear 
that IAH significantly depletes intravascular volume and that 
these changes in preload status are appropriately detected 
by volumetric measurements of intravascular volume such 
as RVEDVI or GEDVI, this does not apply to pressure-based 
measurements such as PAOP and CVP. 
IMPROVEMENT OF VOLUMETRIC PRELOAD INDICES 
IAH, as discussed above, commonly results in cardiac 
dysfunction and decreased EF, which are identified by de-
creases in RVEF and GEF. As a result of this constantly chang-
ing ventricular compliance, there cannot be a single value of 
RVEDVI or GEDVI that can be considered the goal of resusci-
tation for all patients with IAH or ACS [27, 28]. Each patient 
must therefore be resuscitated to the end-diastolic volume 
that optimizes cardiac preload and systemic perfusion in 
that particular situation and at that particular moment in 
time during his or her critical illness. By “correction” of the 
Figure 3. Calculation of the abdomino-thoracic index (ATI) of trans- 
mission at the bedside. Simultaneous central venous pressure (CVP) 
and intra-abdominal pressure (IAP) tracing before and during 
abdominal compression (e.g. by applying an abdominal velcro 
belt). The abdomino-thoracic index of transmission (ATI) can be 
calculated as follows: the change in end-expiratory CVP (∆CVPee 
= 13.5 – 8.5 mm Hg = 5 mm Hg) divided by the change  
in end-expiratory IAP (∆IAPee = 11 – 2 = 9 mm Hg) and expressed 
as a percentage. The abdomino-thoracic index (ATI) of trans-
mission = ∆CVP/∆IAP = 5/9 = 55.6%
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GEDVI for the underlying GEF the predictive power for GEDVI 
as preload parameter or even fluid responsiveness indicator 
improves [34]. This is illustrated in Figure 4.
EFFECT OF INTRA-ABDOMINAL HYPERTENSION  
ON CONTRACTILITY
PATHOPHYSIOLOGY
Diaphragmatic elevation and increased ITP can also 
have marked effects on cardiac contractility via direct car-
diac compression and increased ITP (Fig. 1). Compression 
of the pulmonary parenchyma increases pulmonary artery 
pressure (PAP) and pulmonary vascular resistance (PVR), 
while simultaneously reducing left ventricular preload. As 
right ventricular afterload increases, the right side of the 
heart must play a more active role in maintaining CO. In re-
sponse, the thin-walled right ventricle dilates with a decrease 
in RVEF. The interventricular septum may bulge into the left 
ventricular chamber impeding left ventricular function with 
further decreases in CO. Cardiac ultrasound can provide use-
ful information in patients with IAH [35, 36]. Animal studies 
have shown consistently a drop in CO with increases in IAP 
[9, 17, 22, 37]. This is illustrated in Figure 5. Right ventricular 
dysfunction can become severe in the presence of marked 
IAH leading to significant reductions in left ventricular con-
tractility as a result of “interventricular interdependence” [38, 
39]. In a dog model where IAP was increased up to 40 mm Hg 
with fluid infusion in the peritoneal cavity, a rightward and 
downward shift of the Frank-Starling curve was observed [40]. 
Huetteman et al. showed that anteroseptal left ventricle wall 
motion assessed with transesophageal echocardiography 
was significantly decreased at IAP levels of only 12 mm Hg 
in 8 children during laparoscopic hernioraphy [41, 42]. In 
patients with congestive heart failure, increased CVP and in-
creased IAP are independent predictors for the development 
of acute renal failure [43]. This association has recently been 
termed cardio-abdomino-renal syndrome or CARS [4]. While 
initially responsive to fluid loading and inotropic support at 
lower levels of IAH, the reduced biventricular contractility of 
advanced IAH/ACS can only be effectively treated by nonop-
erative measures to reduce IAP or abdominal decompression.
IMPORTANCE OF ABDOMINAL PERFUSION PRESSURE
During the early evolution of IAH and ACS, attempts 
were made to identify a single “critical” IAP that could be 
used to guide decision making concerning patients with 
IAH. This oversimplifies what is actually a highly complex 
and variable physiologic process. While IAP is a major de-
terminant of patient outcomes during critical illness, the IAP 
that defines both IAH and ACS clearly varies from patient to 
patient, and even within the same patient, as their disease 
process evolves [2, 44, 45]. As a result, a single threshold 
value of IAP cannot be globally applied to decision mak-
ing regarding all critically ill patients (Fig. 6) [46]. In order 
to improve the sensitivity of IAP for decision making, one 
can include it in an assessment of abdominal perfusion 
pressure (APP) as a resuscitation endpoint. Similar to the 
widely accepted and utilized concept of cerebral perfusion 
pressure (CPP), APP, calculated as MAP minus IAP, has been 
Figure 4. Ventricular Function Curves by by Global Ejection Fraction 
(GEF) and Right Ventricular Ejection Fraction (RVEF). Cardiac 
contractility in the critically ill can be described as a series of 
“ventricular function curves”. Each curve has an associated ejection 
fraction, describing the ventricle’s contractility, and an optimal 
end-diastolic volume, identifying the plateau of the ventricular 
function curve. Resuscitation to this plateau end-diastolic volume is 
widely believed to optimize a patient’s intravascular volume, cardiac 
function, and end-organ perfusion. As ventricular function changes, 
the patient “shifts” from one Frank-Starling curve to another with the 
identification of both a new, optimal plateau end-diastolic volume 
as a resuscitation endpoint and a new ejection fraction. Therefore, 
the patient’s global end-diastolic volume index (GEDVI) and right 
ventricular end-diastolic volume index (RVEDVI) must be interpreted 
in conjunction with the patient’s GEF or RVEF. Adapted from Malbrain 
et al. [34].
Figure 5. Frank Starling curves with suggested effects on left 
ventricular (LV) compliance related to increased intra-abdominal 
pressure. Especially in the “middle zone” of normovolemia (between 
dotted vertical lines), increased IAP (dotted Frank-Starling line) 
can have deleterious effects on LV compliance making a correct 
assessment of fluid responsiveness important. The ΔP indicates 
a change in preload versus ΔSV, the resulting change in stroke 
volume
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proposed as a more accurate marker of critical illness and 
endpoint for resuscitation in patients with IAH, although 
a large prospective multicentric validation of this parameter 
is still pending.
APP = MAP − IAP
Target APP values can be achieved through a balance of 
judicious fluid resuscitation and the application of vasoac-
tive medications. Maintaining an APP of 50 to 60 mm Hg 
may appear to be a better resuscitation endpoint compared 
to other macro and microcirculatory parameters. Multiple 
regression analysis has demonstrated that APP is superior 
as a resuscitation endpoint parameter compared to arterial 
pH, base deficit, arterial lactate, and hourly urinary output in 
surgical patients [47]. The authors concluded that using APP 
can allow one to predict survival from IAH or ACS that is not 
identified by IAP alone [47]. However, studies with regard to 
APP are scarce, often retrospective and include only small 
patient numbers. Therefore, APP as a resuscitation parameter 
cannot be recommended based on the current literature. 
USE OF TRANSPULMONARY THERMODILUTION IN IAH
The continuous CO measured by TD or pulse contour 
with different devices (Pulsioflex, PiCCO, Swan Ganz) showed 
good agreement with TPTD in 10 pigs without IAH, and re-
flected an increase in CO following fluid loading [48]. Induc-
tion of IAH via the pneumoperitoneum did not significantly 
influence the CO measured by all devices. However, in IAH, 
an increase in CO following fluid loading was indicated by 
calibrated CO but not by uncalibrated CCO methods us-
ing arterial waveform analysis. In the critically ill patient, 
recalibration of continuous arterial waveform CO methods 
should be performed after fluid loading or before a major 
change in treatment is initiated [49]. The relative position 
of the catheters used for TPTD measurements may also 
be relevant. Huber et al. found that performing TPTD via 
a femoral central venous line (CVL) had a significant impact 
on the calculated variables [50]. Thus, they found that CI 
measured with TPTD via a jugular CVL can be calculated 
with the following formula: 
0.931 × CIfem + 1.45 − 0.00042 × GEDVIfem + 0.028 ×  
CVPfem − 0.009 × height
(with CIfem, GEDVIfem and CVPfem respectively the CI, 
GEDVI and CI when measured with TPTD  
via a femoral CVL).
Since IAP and CVPfem are closely related especially from 
grade III to IV IAH, this formula suggests that IAP may have 
an impact on TPTD CI when bolus injection is performed via 
a femoral CVL [18, 51]. The GEDVI and EVLWI values were 
also affected when performing TPTD via a femoral CVL. 
This phenomenon can be explained by the fact that the 
calculation of these volumetric parameters is based upon 
the MTT and DST, and since venous return is diminished in 
IAH, transit times may be affected when the thermodilution 
bolus is injected via the femoral CVL.
EFFECT OF INTRA-ABDOMINAL HYPERTENSION  
ON AFTERLOAD
Elevated ITP and IAP can cause increased systemic 
vascular resistance (SVR) through direct compressive ef-
fects on the aorta and systemic vasculature and increased 
PVR through compression of the pulmonary parenchyma. 
Organ compression may also result in alterations in the 
renin-angiotensin-aldosterone mechanism [11, 52]. More 
commonly, however, increased SVR occurs as compensation 
for the reduced venous return and falling stroke volume 
outlined above. As a result of this physiologic compensation, 
MAP typically remains stable in the early stages of IAH/ACS 
despite reductions in venous return and cardiac output. 
These increases in afterload may be poorly tolerated by 
patients with impaired cardiac contractility or inadequate 
intravascular volume [27, 53−55]. 
The concept of abdominal vascular zones may be pre-
sent in the patient with IAH, analogous to the pulmonary 
vascular zone conditions described by West. In this con-
cept, an increased IAP increases venous return when the 
transmural IVC pressure (defined as IVC pressure minus 
IAP) at the thoracic inlet significantly exceeds the critical 
closing transmural pressure (=zone 3 abdomen) [15]. This 
is most often the case in hypervolemic patients with a high 
IVC pressure. In zone 3 conditions, the abdominal venous 
compartment functions as a capacitor. In contrast, when 
Figure 6. Distinctions between normal intra-abdominal pressure, 
intra-abdominal hypertension (IAH), and abdominal compartment 
syndrome (ACS). The shaded area illustrating IAH may undergo shifts 
to the right or left depending on the clinical scenario. Courtesy of 
David J.J. Muckart, MD, University of Natal Medical School, Republic 
of South Africa, and Rao Ivatury, MD, PhD, Virginia Commonwealth 
University, Virginia, USA, and adapted from Malbrain et al. [46]
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the transmural IVC pressure at the thoracic inlet is below 
the critical closure transmural pressure (=zone 2 abdomen), 
venous return is significantly decreased. This is most often 
the case in hypovolemic patients and by extension in most 
non-cardiogenic shock patients. In zone 2 conditions, the 
abdominal venous compartment functions as a collapsible 
starling transistor [56]. This model clearly illustrates why 
hypovolemia (and especially in combination with positive 
pressure ventilation and high levels of PEEP) predisposes 
patients to lower CO in response to elevated IAP than does 
normovolemia [57].
For the same reasons mean systemic filling pressure 
may also increase during IAH as was found in pregnant 
woman with pre-eclampsia [58]. This may explain the 
marked susceptibility to pulmonary edema seen with even 
minimal volume administration.
USE OF FUNCTIONAL HEMODYNAMICS IN IAH
IMPACT OF IAP ON FLUID RESPONSIVENESS
An increase in IAP will result in a concomitant increase 
in ITP and, as such, also in an increase in stroke volume 
variation (SVV) and pulse pressure variation (PPV) [59, 60]. 
Other studies have also shown increases in systolic pres-
sure variation (SPV) that were mainly related to the Δup 
component and not to a Δdown phenomenon. As different 
mechanisms have been suggested, the increases seen in 
functional hemodynamic parameters may not univocally 
correspond to fluid responsiveness [61]. These include the 
following firstly, a change in aortic compliance and an in-
crease in aortic transmural pressure induced by increased 
IAP (either via direct compression or increased vasomotor 
tone); secondly, errors in the measurement of dynamic in-
dices in conditions of increased IAP, or, if we assume that no 
measurement errors are induced by IAP, then this implies 
that these indices do not perform well during IAH (since SVV 
and SPV no longer predict fluid responsiveness); and thirdly, 
changes in extramural pressure, ITP or chest wall compli-
ance. Although in several animal studies, PPV (but not SVV) 
maintained its ability to predict fluid responsiveness even at 
IAP levels of 25 mm Hg, a receiver operating characteristics 
(ROC) curve analysis identified 20.5% as the best threshold 
for fluid responsiveness (instead of the classical 12% and 
the 9.5% identified in this study at baseline) [62−64]. This 
means that we cannot use the same thresholds for different 
conditions. The threshold value will depend on the amount 
of tidal volume, PEEP application or increased ITP and con-
sequent changes in pleural pressure and chest wall compli-
ance, the presence of obesity, heart failure with changes 
in right and left ventricular preload and afterload, pulmo-
nary hypertension, the use of a pneumoperitoneum or in-
creased IAP and may also differ in children or neonates [65]. 
Moreover, PPV has been shown to be superior to SVV in 
order to predict fluid responsiveness in the patients. This is 
somewhat surprising since PPV is a surrogate of SVV (derived 
from a pulse contour analysis based on a complex algo-
rithm) and the latter should be less influenced by changes 
in vasomotor tone. Changes in pulse contour due to in-
creased ITP may be more complex than previously thought. 
A recent animal study on severe pancreatitis showed that 
goal-directed hemodynamic management guided by SVV 
led to improved survival, tissue oxygenation, and microcir-
culatory perfusion, as well as less histopathologic damage 
[66]. Although the authors did not measure actual IAP, the 
model was interesting and can provide useful information 
for patients with IAH [67].
VALIDITY OF THE PASSIVE LEG RAISING  
TEST IN IAH 
Recent data have shown that about 25% of critically 
ill patients with a PPV above 12% are not fluid responsive, 
suggesting different thresholds for different conditions [68]. 
Similar false positive PPV values have been reported previ-
ously and were related to right ventricular dysfunction. 
This also shows that the PLR test can be a false negative 
in responders to fluid administration and this can be re-
lated to increased IAP and diminished venous return from 
the legs and mesenteric veins. Care should be taken when 
a PLR test is performed, and an IAP measurement is needed 
whilst interpreting the result of a PLR test. The PLR test is 
difficult to standardise since it does not provide informa-
tion on the exact amount of endogenous transfusion and 
there is some debate whether the starting position should 
be supine or upright (HOB) or whether the Trendelenburg 
position should be used. In fact, depending on patient an-
thropomorphism, the amount of fluid loading with a PLR 
may vary. During IAH one can expect an increase in baseline 
PPV especially in the 45° HOB position (Fig. 7). Performing 
a PLR maneuver from HOB (with the least risk for ventila-
tor associated pneumonia) will further increase IAP and 
will only result in a marginal venous return from the legs 
but not from the mesenteric veins. Performing a PLR ma-
neuver from the supine position will have a neutral effect 
on IAP and result in a better venous return from the legs 
but not from the mesenteric veins. At the same time, the 
Trendelenburg position will have a beneficial effect on IAP 
and, depending on body anthropomorphism, will result in 
a more pronounced venous return from the legs, as well as 
from the mesenteric veins [69].
CARDIOVASCULAR OPTIMIZATION IN IAH
IMPROVEMENT OF PRELOAD
Although initial fluid loading may improve venous re-
turn and restore CO, fluid overload must be avoided, espe-
cially in the setting of a capillary leak [70, 71]. To solve this 
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problem, the use of colloids or hyperoncotic solutions like 
hypertonic lactated saline or albumin 20% have been shown 
to reduce fluid intake whilst at the same time preserving 
urine output in severely burnt patients [72, 73]. The net result 
was a lower IAP and higher APP [72]. An important question 
in these patients is whether they are truly volume depleted, 
Figure 7. Comparison of different types of passive leg raising tests. The PLR can be performed from HOB (first row) or supine (second row) position 
or putting the patient in the Trendelenburg position (third row). Panel A shows the effects of different PLR tests in patients with normal IAP while 
Panel B hypothesizes on the effects in patients with IAH. Endogenous fluid resuscitation comes from venous return from the legs (oblique arrow) 
and the mesenteric veins (horizontal arrow). The amount endogenous fluid resuscitation is indicated by the thickness of the arrow (dotted line 
is smallest while 3mm line is largest amount), a dotted line marked with a “X” indicates the absence of endogenous transfusion (adapted from 
Malbrain et al. [69]); HOB — head of bed; IAH — intra-abdominal hypertension; IAP — intra-abdominal pressure; ICP — intra cranial pressure; 
PLR — passive leg raising; PPV — pulse pressure variation; SUP — supine; VAP —ventilator associated pneumonia; á — increase; áá — huge 
increase; ä — small increase; æ— small decrease; â — decrease; ââ — huge decrease
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and the use of parameters such as those mentioned above 
should always be correlated with clinical parameters of 
volume depletion. As fluids are the major contributor to 
secondary ACS, the judicious use of fluids is recommended 
[74]. As for all organ dysfunctions, decreasing IAP is another 
effective way of decreasing the negative cardiac effects 
described above.
IMPROVEMENT OF CONTRACTILITY
Non-operative measures to decrease IAP will result 
in a caudal movement of the diaphragm and decrease of 
cardiac compression, while the concomitant drop in ITP 
will improve cardiac contractility. After the initial resuscita-
tion, a positive inotrope like dobutamine, levosimendan or 
milrinone can be considered if the patient has a low CO, 
increased lactate or low ScvO2. Although dobutamine infu-
sion reverses the decrease in CO, it cannot restore superior 
mesenteric artery blood flow; however, intestinal mucosal 
blood flow returns to baseline levels [75]. Dopamine should 
not be used, since studies have shown no beneficial effect 
on splanchnic hemodynamic variables [75]. 
IMPROVEMENT OF AFTERLOAD
Preload augmentation through volume administration 
appears to ameliorate, at least partially, the injurious effects of 
IAH-induced increases in afterload. It has also been proposed, 
that the use of a moderate level of PEEP might efficiently 
reduce the increase in ventricular afterload [37, 40, 76, 77].
CONCLUSIONS AND KEY MESSAGES
 — Cardiovascular dysfunction and failure (low CO, low 
contractility, high SVR) are common in IAH or ACS.
 — Clinical evaluation of a patient is essential when inter-
preting the hemodynamic parameters obtained.
 — Before administering fluids to patients with IAH or ACS, 
carefully check whether the patient is truly intravascular 
fluid depleted – do not act solely on preload parameters.
 — Accurate assessment and optimization of preload, con-
tractility, and afterload is essential to restore end-or-
gan perfusion and function.
 — Traditional hemodynamic monitoring techniques must 
be re-evaluated in IAH/ACS since pressure-based esti-
mates of intravascular volume as PAOP and CVP can be 
erroneously increased. 
•	 The clinician must be aware of the interactions be-
tween ITP, IAP, PEEP, and intracardiac filling pres-
sures.
•	 Misinterpretation of the patient’s minute-to-minute 
cardiac status may result in the administration of in-
appropriate and potentially detrimental treatment.
•	 Transmural filling pressures may better reflect 
preload in the setting of increased IAP.
•	 The mean systemic filling pressure may increase in IAH.
•	 The Surviving Sepsis Campaign guidelines targeting 
initial and ongoing resuscitation towards a CVP of 
8 to 12 mm Hg and other studies targeting a MAP 
of 65 mm Hg should be interpreted with caution in 
cases of IAH/ACS to avoid unnecessary over- and 
under resuscitation. 
•	 There is insufficient data to recommend resuscita-
tion towards an APP > 60 mm Hg.
 — Volumetric estimates of preload status such as right 
ventricular end-diastolic volume index (RVEDVI), global 
end-diastolic volume index (GEDVI) or left ventricular 
end-diastolic area (LVEDA), can be useful because of 
the changing ventricular compliance with elevated ITP.
 — Clinicians must be aware of abdominal West abdominal 
zones. 
 — Although functional hemodynamic parameters such as 
PPV (but not SVV nor SPV) should be used to assess volume 
responsiveness, the traditional thresholds need to revised.
•	 About 25−35% of patients with IAH and a PPV > 12% 
are non-responders to fluids.
•	 The best threshold to predict fluid responsiveness 
in grade II IAH (15 to 20 mm Hg) is a PPV > 20%.
 — IAH can be a cause of a false negative passive leg rais-
ing test.
 — IAH causes pulmonary hypertension via increased ITP with 
direct compression on lung parenchyma and vessels and 
via the diminished left and right ventricular compliance.
 — Transpulmonary thermodilution CO measurements are 
validated in the setting of IAH.
 — Cardiovascular effects are aggravated by hypovolemia 
and the application of PEEP, whereas hypervolemia has 
a temporary protective effect.
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